FDA Investigator Ramon E Martinez

Ramon E Martinez has inspections in 4 countries as of 30 Aug 2023. Ramon E Martinez has collaborated with a combinined 5433 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
55
Last Inspection Date:
30 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, France, Denmark, India
Co-Investigator(s):
Abdur Rafay Shareef, Aireen V Mendoza, Alan R Condon, Alice C Silva, Alla Kachko, PhD, Allison A Aldridge, PhD, Allison A Rodriguez, Almaris N Alonso, Amber G Wardwell, Amy C Jordan, Anastasia I Offordile, Andrew M Barlow, Angela E Glenn, Anissa M Cheung, Anita R Michael, Ann L Demarco, Ann Marie Montemurro, Ann Marie Schofield, Anne Marie Dubrey, Anthony C Warchut, Anthony W Thomas, Arie C Menachem, Ashley J Burns, Ashley M Whitehurst, Audrey Thereset Uy, Bo Chi, PhD, Bradley D Newsad, Brenda P King, Brenda W Uratani, PhD, Brentley S Collins, Brian S Keefer, Byungja E Marciante, Camerson E Moore, Candace Y Gomez Broughton, Carla J Lundi, Carlos Chavez, Cassandra L Abellard, Catherine J Laufmann, CDR Donald Ertel, CDR Jeremy L Wally, PhD, Chao Ming Tsai, Charisse K Green, Charles R Cote, RIC, Charles Yuanchia Kuo, PhD, Cheryl A Clausen, Christian D Lynch (CDL), Christina J Sauder, PhD, Christine L Williams, Christopher J Adams, Christopher Janik, Constance Desimone, Courtney N Long, Craig D Zagata, Cynthia Jim, CSO, Daniel L Zheng, Darin S Wiegers, Daryl A Dewoskin, Dave Hafner, David J Hafner, David P Vanhouten, David Van Houten, Debra J Bennett, Debra L Pagano, Dell S Moller, Demitria J Xiradakis, Dennis Cantellops Paite, Devaughn Edwards, Dien N Nguyen, Donald C Obenhuber, PhD, Donna J Clevenger, Dorothy W Lee, Douglas A Campbell, Douglas S Joslin, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edmund Fmrak J, Eileen A Liu, Elizabeth Ll Edwards, Ellen Huang, Ellen P Madigan, Erik W Koester, Erin P Conlin, Felix Maldonado, Frank P Hurst, Frederick Razzaghi, Gary J Hagan, Gene D Arcy, George M Ibrahim, George T Allen, Jr, Ginger M Sykes, Hala L Selby, Haley H Seymour, Harperd, Haruhiko Murata, Helen B Ricalde, Holly Brevig, J David Doleski, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James L Dunnie, Jr, James M Mason, James W Whitney, Jason A Rossi, Jawaid Hamid, Jayaleka J Amarasinghe, Jeremy W Rotton, Jianming Li, Joan A Loreng, Joan Adamo, Joanne E King, Joanne M Hajoway, John A Sciacchitano, John P Mistler, John P Shelton, John R Carlson, John S Hartford, Jonah S Ufferfilge, Jonathan G Matrisciano, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose O Hernandez, Jose Ohernandez Guzman, Joseph George, Joseph H Procopio, Joyce A Kellett, Juanita P Versace, Jude C Dikes, Julianne C Mccullough, Julie A Finegan, June P Page, Junho Pak, Justin A Boyd, Justine M Corson, Kalavati Suvarna, PhD, Karyn M Campbell, Katherine D Adams, Kathleen B Mihalik, Kathryn Carbone, MD, Kathy E Craven, Kathy E Noe, Katie L Korchinski, Kelly N Kerr, Kenneth H Williams, Kenneth M Gordon, Kent A Conforti, Kevin A Gonzalez, Kristen D Evans, Kristina J Donohue, L Norwood, Laura Fontan, MS, Lauren M Lawrance, Laurie B Frazier, Laurie Graham, Lawton W Lum, LCDR Chad N Thompson, LCDR Debra Emerson, LCDR Margaret E Digennaro, Leo B Zadecky, Linda Thai, Lisa Feela, Lisa M Bellows, Lori A Holmquist, Lori M Newman, LT John M Mastalski, Lydia Irosas Marty, Lydia S Chan, M Pedgen, Margaret E Walsh, Margaret M Sands, Marian E Major, PhD, Marion Michaelis, Mariza M Jafary, Mark E Parmon, Mark R Mcclain, Marlene G Swider, Martin J Guardia, Mary Jeanet Mcgarry, Matthew C Watson, Matthew D Silverman, Maura Rooney, Maya M Davis, Megan A Haggerty, Megan A, Haggerty, Michael A Charles, Michael Curbag, Michael Gurbarg, Michael J Casey, Michael P Anthony, Michael P Sheehan, Michael P Sweeney, Michael Serrano, Michele Perry Williams, Michelle M Noe, Michelle Y Clark Stuart, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Minh D Phan, Monique C Lo, Mra Davism, Mra Mcculloughj, Nadeem I Chaudhry, Nealie C Newberger, Nicholas A Violand, Nicholas B Murphy, Nichole B Murphy, Nicole E Knowlton, Nicole K Trudel, Obinna R Echeozo, Omotunde O Osunsanmi, Osama A Khatib, Pamela L Lee, Pamela L Ogonowski, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patricia Fhughes Troost, Paul L Bellamy, Paul P Geraci, Paula A Trost, Pei I Chu, Pete Amin (Pankaj), Philip F Istafanos, DMV, MS, Philip Kreiter, Phillip E Mclaughlin, Prabhu P Raju, Rachael O Oyewole, Raeann R Wu, Rajiv R Srivastava, Ralph H Vocque, Ranjani Prabhakara, Rashmi Rawat, PhD, Rebecca E Dombrowski, Rebecca K Olin, Richard H Penta, Richard L Friedman, Robert B Shibuya, MD, Robert D Tollefsen, Robert J Martin, Robert Mo Brien, Rory K Geyer, Rose M Ashley, Satheesh Thomas, Scott B Laufenberg, Scott C Lute, Scott E Norris, Scott Lute, Scott R Nichols, PhD, Scott T Ballard, Sean R Marcsisin, Sharon K Thoma, PharmD, Sheila Dreher Lesnick, Shirley J Berryman, Shuang Tang, Simone E Pitts, Sixto M Mercado Rios, Slater K Bartlett, Stacey S Degarmo, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephen C Smith, Stephen D Brown, Stephen D Eich, Stephen R Souza, Steven A Rubin, Steven B Hertz, Steven Fong, MS, PhD, Steven M Weinman, Sunita Pandey, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susanne M Richardson, MSc RAC ELS, Susant Hadman, Suzanne M Healy, Tammy L Chavis, Teddy Tom, Teresa I Navas, Theresa To, Thomas J Arista, Thomas Siebertz, Thomas W Nerney, Timothy M Glod, Tina S Roecklein, Towanda L Terrell, Troy R Petrillo, Unnee Ranjan, Valentino Fiorella, Vlada Matusovsky, Wayne E Seifert, Wei Wang, PhD, Wendy A Johnecheck, William J Leonard, William K Dagley, William S Boivin, Xiao Wang, Xiaokuang Lai, PhD, Xiaoping Guan, Yehualashet A Gessesse, Ying Xin Fan, PhD, Yumi J Hiramine, Zhichao Lin, Zhongren Wu

Ramon E Martinez's Documents

Publish Date Document Type Title
September, 2013 FDA 483 Lonza Biologics, Inc. - Form 483, 2013-09-30
December, 2008 FDA 483 Genzyme Corporation - Form 483, 2008-12-05
May, 2012 FDA 483 AllerQuest LLC - Form 483, 2012-05-18
May, 2014 FDA 483 AMAG Pharmaceuticals, Inc. - Form 483, 2014-05-21
April, 2011 FDA 483 AstraZeneca LP - Form 483, 2011-04-27
January, 2013 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2013-01-29
October, 2010 FDA 483 Formatech Inc. - Form 483, 2010-10-15
February, 2011 FDA 483 Alexion Pharmaceuticals, Inc. - Form 483, 2011-02-18
October, 2011 FDA 483 Genzyme Corporation - Form 483, 2011-10-27
August, 2009 FDA 483 Shamrock Medical Solutions Group LLC - Form 483, 2009-08-11
May, 2014 EIR AMAG Pharmaceuticals, Inc. - EIR, 2014-05-21
July, 2013 FDA 483 Lyophilization Services of New England, Inc. - Form 483, 2013-07-31
November, 2012 FDA 483 Ameridose, LLC - Form 483, 2012-11-09
May, 2013 FDA 483 CIPLA LIMITED - Form 483, 2013-05-30
October, 2008 FDA 483 AMAG Pharmaceuticals, Inc. - Form 483, 2008-10-22
March, 2012 FDA 483 Novo Nordisk A/S - Form 483, 2012-03-20
January, 2012 FDA 483 Shire Human Genetics Therapies, Inc. - Form 483, 2012-01-11
February, 2013 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2013-02-19
August, 2014 FDA 483 Johnson Memorial Cancer Center - Form 483, 2014-08-05
September, 2013 EIR Lonza Biologics, Inc. - EIR, 2013-09-30
October, 2010 FDA 483 Genzyme Corporation - Form 483, 2010-10-22
July, 2014 FDA 483 Cubist Pharmaceuticals, Inc. - Form 483, 2014-07-10
January, 2010 FDA 483 Braintree Laboratories, Inc. - Form 483, 2010-01-22
July, 2009 FDA 483 The Dodge Company, Inc. - Form 483, 2009-07-02
August, 2011 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2011-08-11
October, 2008 FDA 483 Response AMAG Pharmaceuticals, Inc. - Form 483R, 2008-11-03
March, 2012 EIR Novo Nordisk A/S - EIR, 2012-03-20
June, 2009 FDA 483 Cambridge Isotope Laboratories, Inc. - Form 483, 2009-06-18
April, 2013 FDA 483 Pallimed Solutions, Inc. - Form 483, 2013-04-09
December, 2013 FDA 483 N-Molecular, Inc. dba SOFIE - Form 483, 2013-12-11
December, 2011 FDA 483 Millennium Pharmaceuticals, Inc. - Form 483, 2011-12-16
April, 2010 FDA 483 Curia Massachusetts, Inc. - Form 483, 2010-04-01
August, 2010 FDA 483 Fresenius Medical Care Holdings, Inc. - Form 483, 2010-08-06

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more